The University of Chicago Header Logo

Connection

Ravi Salgia to Neoplasms, Multiple Primary

Back to Details
This is a "connection" page, showing publications Ravi Salgia has written about Neoplasms, Multiple Primary.
Ravi Salgia
Connection Strength
0.875
Neoplasms, Multiple Primary
  1. Complete response to chemoimmunotherapy with bevacizumab in synchronous multiple primary cancers: pulmonary adenocarcinoma and sarcomatoid carcinoma. Cold Spring Harb Mol Case Stud. 2023 04; 9(2).
    View in: PubMed
    Score: 0.875
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.